Emergency icon Important Updates

David Peter, MD, MBA

David Peter, MD, MBA
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Title Vice President and Chief Medical Officer, Cleveland Clinic Indian River Hospital
Department Executive Administration Florida
Primary Location Cleveland Clinic Florida, Indian River Hospital
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Insurance

Insurance

Is Cleveland Clinic Florida Part of Your Insurance?

Review a list of accepted insurance plans for our Florida locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About David Peter, MD, MBA

Dr. David Peter serves as the Vice President and Chief Medical Officer at Cleveland Clinic Indian River Hospital. His role is integral in leading the hospital's strategic direction and performance, where he works closely with institute leaders and Cleveland Clinic management. His leadership encompasses the administration and management of hospital programs and initiatives, spearheading quality improvement projects in hospital and outpatient settings, and strategically driving the growth of service lines and the overall development of the hospitals.

Dr. David Peter is board-certified in Hospice and Palliative Medicine, in addition to Emergency Medicine. Before serving as the Chief Medical Officer at Cleveland Clinic Indian River Hospital, Dr. Peter held the same position at Cleveland Clinic Akron General. In addition to CMO responsibilities, he is currently the Documentation Excellence Executive Physician Champion for CC Florida and a Medical Director for Mergers and Acquisitions Informatics.

Dr. Peter received his medical degree and residency training in Emergency Medicine at the University of Cincinnati, a top-ranked program and the first Emergency Medicine program in the United States. He completed his MBA through the University of Massachusetts Amherst, Isenberg School of Management.

Prior experience includes Chief Medical Information Officer, Care Management, Medical Operations, and Revenue Cycle. He has over 30 years of experience in leadership, including documentation and coding and has led successful Clinical Documentation Integrity and Coding teams. Dr. Peter has authored many journal articles, book chapters and abstracts, in addition to actively participating on several community boards.
Education & Professional Highlights

Education & Professional Highlights

Appointed
2019

Education & Fellowships

Graduate School - University of Massachusetts
Business
Amherst, MA USA
2011

Residency - University of Cincinnati College of Medicine, Department of Emergency Medicine
Emergency Medicine
Cincinnati, OH USA
1991

Medical Education - University of Cincinnati College of Medicine
Medicine
Cincinnati, OH USA
1987

Undergraduate - Thomas More College
Biology
Crestview Hills, KY USA
1980

Certifications

  • Emergency Medicine - Hospice and Palliative Medicine
Research & Publications

Research & Publications

See publications for David Peter, MD, MBA.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/11/2023, Dr. Peter has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top